In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.

On the basis of preliminary in vitro data, we evaluated E-1040, a new cephalosporin, against 188 cystic fibrosis (CF) sputum isolates obtained from 26 CF centers in the United States. These isolates included mucoid and nonmucoid Pseudomonas aeruginosa, Pseudomonas cepacia, Staphylococcus aureus, Hae...

Full description

Bibliographic Details

Published in:	Antimicrob Agents Chemother
Main Authors:	Stutman, H R, Akaniro, J C, Vidaurre, C E, Marks, M I
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 1990
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175982/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2386368/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.7.1366
Tags:	Add Tag No Tags, Be the first to tag this record!